Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy

Journal of Clinical Oncology

Volumn 25, Issue 25, 2007, Pages 3866-3870

  Ferguson, Robert J ^a   McDonald, Brenna C ^a   Saykin, Andrew J ^a   Ahles, Tim A ^a  

^a EASTERN MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; TAMOXIFEN; ANTINEOPLASTIC AGENT; APOLIPOPROTEIN E;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; COGNITION; COGNITIVE DEFECT; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MONOZYGOTIC TWINS; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SELF REPORT; WHITE MATTER; WORKING MEMORY; BRAIN; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; HISTOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; SURVIVOR; TWINS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOLIPOPROTEINS E; BRAIN; BREAST NEOPLASMS; COGNITION DISORDERS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SURVIVORS; TAMOXIFEN; TWINS, MONOZYGOTIC;

EID: 34548529337     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.8639     Document Type: Article

References (23)

1. Ferguson RJ, Ahles TA: Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep 3:215-222, 2003
2. Minisini A, Atalay G, Bottomley A, et al: What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 5:273-282, 2004
3. Phillips KA, Bernhard J: Adjuvant breast cancer treatment and cognitive function: Current knowledge and research directions. J Natl Cancer Inst 95:190-197, 2003
4. Ahles TA, Saykin AJ, Furstenberg CT, et al: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493, 2002
5. van Dam FS, Schagen SB, Muller MJ, et al: Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: High dose versus standard dose chemotherapy. J Natl Cancer Inst 90:210-218, 1998
6. Jenkins V, Shilling V, Deutsch G, et al: A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828-834, 2006
7. Donovan KA, Small BJ, Andrykowski MA, et al: Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104:2499-2507, 2005
8. Silverman DH, Dy CJ, Castellon SA, et al: Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat 103:303-311, 2007
9. Ahles TA, Saykin AJ, Noll WW, et al: The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12:612-619, 2003
10. DeCarli C, Reed T, Miller BL, et al: Impact of apolipoprotein E e-4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke 30:1548-1553, 1999
11. Haan MN, Shemanski L, Jagust WJ, et al: The role of APOE e-4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40-46, 1999
12. Delis DC, Kramer JH, Kaplan E, et al: California Verbal Learning Test-II. San Antonio, TX, The Psychological Corporation, 2000
13. Craft S, Newcomer J, Kanne S, et al: Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 17:123-130, 1996
14. Wechsler D: Wechsler Adult Intelligence Scale-3rd Edition (WAIS-III). San Antonio, TX, Harcourt, Brace & Co, 1997
15. Delis DC, Kaplan E, Kramer JH: Delis-Kaplan Executive Function System. San Antonio, TX, The Psychological Corporation, 2001
16. Seidenberg M, Haltiner A, Taylor MA: Development and validation of a multiple ability self-report questionnaire. J Clin Exp Neuropsychol 16:93-104, 1994
17. Spielberger CD, Gorsuch RL, Lushene RG: Manual for the State-Trait Anxiety Inventory. Palo Alto, CA, Consulting Press, 1971
18. Radloff LS: The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1:385-401, 1977
19. McAllister TW, Saykin AJ, Flashman LA, et al: Brain activation during working memory 1 month after mild traumatic brain injury: A functional MRI study. Neurology 53:1300-1308, 1999
20. McAllister TW, Sparling MB, Flashman LA, et al: Differential working memory load effects after mild traumatic brain injury. Neuroimage 14:1004-1012, 2001
21. Saykin AJ, Wishart HA, Rabin LA, et al: Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127:1574-1583, 2004
22. Wishart HA, Saykin AJ, McDonald BC, et al: Brain activation patterns associated with working memory in relapsing-remitting MS. Neurology 62:234-238, 2004
23. Saykin AJ, Wishart HA, Rabin LA, et al: Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 67:834-842, 2006